Why Russian peptides? Tradition and quality

“Russian peptides” is often a brand on the market, not a scientific category. Yet behind the label stands a real tradition: in the Soviet Union and Russia, peptides, neuropeptides and their effects on ageing, immunity and the nervous system were studied for decades.

This article explains what is real in that tradition, what is myth, and how to judge quality regardless of origin.

Historical context

The Russian peptide school emerged in an environment where research focused on:

• neuroendocrine regulation;
• peptides as signalling molecules;
• regulation of ageing;
• the immune system and the thymus;
• the pineal gland and melatonin.

Better-known examples include Semax (an ACTH(4–10) analogue), Selank (a tuftsin analogue), Epitalon (the AEDG tetrapeptide) and Thymalin (a thymus preparation). Some of these compounds were registered in Russia as medicines for certain indications, which is important context but does not mean they are approved in the EU.

What has the “Russian school” actually contributed?

The contributions are mainly at the level of hypotheses and early research:

1. The idea that short peptides can be biologically active and specific.
2. Research into hormone fragments (e.g. ACTH) with fewer systemic effects.
3. Linking peptides to ageing and immunosenescence.
4. The development of intranasal peptide preparations.

At the same time, the literature is often methodologically limited: small samples, limited blinding, publication in domestic journals and rare independent replication. This must be taken into account when reading.

Origin is not a guarantee of quality

A peptide synthesised in Russia is not automatically better or worse than one synthesised in the EU or Asia. Quality is determined by:

• the quality of raw materials;
• the synthesis strategy;
• the purification procedure;
• analysis and validation of methods;
• packaging and storage;
• batch traceability.

Every country has good and bad manufacturers. The only meaningful criterion is therefore documentation for the specific batch, not a geographical label.

How do we select suppliers?

We take several criteria into account:

1. Product identity — exact sequence, molecular mass, form.
2. Analysis — HPLC with a chromatogram and MS with a measured mass.
3. Traceability — batch number on the vial and in the documentation.
4. Stability — storage and shelf-life data.
5. Communication — answers to technical questions.
6. Compliance — a clear research-use marking and realistic claims.

No single criterion is an absolute guarantee, but together they reduce risk.

Five myths about Russian peptides

Myth 1: “Russian peptides are stronger.”

There is no evidence for a general claim. The effect depends on the molecule, dose and receptors, not on the country.

Myth 2: “They are secret military compounds.”

Some research was linked to defence or institutional programmes, but that does not mean commercially available peptides are “secret” or better. Such stories are often marketing.

Myth 3: “If it is a medicine in Russia, it is banned in the EU.”

It is not that simple. Status depends on the European approval procedure. The absence of EU approval does not necessarily mean a ban, but it does mean the product is not an approved medicine.

Myth 4: “Russian peptides are always cheaper.”

Prices are shaped by synthesis, quality and distribution. A cheap offer may be a sign of lower quality or smaller quantity.

Myth 5: “It is enough that it says ‘Russian’.”

A label without documentation is marketing. Ask for the batch, the analysis and clear specifications.

What is genuinely valuable in the Russian tradition?

The greatest value is the diversity of hypotheses that Western literature often overlooks. Compounds such as Semax and Selank are interesting for research into neuroplasticity and stress. Epitalon opens questions about pineal regulation. These hypotheses are worth studying — with better methodology and independent replication.

Conclusion

Russian peptides are a legitimate research tradition, not a guarantee of quality. If their origin appeals to you, let it be the starting point for questions: who is the manufacturer, what is the analysis, where is the batch, and how was the product stored.

For further reading: Semax and Selank, Russian gerontology and the catalogue.